Granules India Limited Press Release Dec 22 2025

About this update from Granules India Limited

Granules India Limited has informed the Exchange regarding a press release dated December 22, 2025, titled "Granules Pharmaceuticals Inc. Receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets (ADZENYS XR-ODT®)". View Attachment

View stock analysis, news, and events for Granules India Limited